Skip to main content

Table 2 Frequencies of expression of the BCR-ABL rearrangements in patients with CML from different studies

From: Chronic myeloid leukemia: cytogenetics and molecular biology’s part in the comprehension and management of the pathology and treatment evolution

Types of BCR-ABL fusion transcripts [50] Mexico N = 250 [51] Iran N = 75 [52] Sudan N = 112 [53] Nigeria N = 42 [54] Indonesia N = 183
b3a2 (e14a2) 35% 63% 5.5% 67.3% 74.3%
b2a2 (e13a2) 48% 20% 19.3% 21.4% 22.4%
b3a2/b2a2 7% 7.3% 1%
e1a2 1%
  1. (N): Number of patients included in the study; (%): Frequency of the variant